Next 10 |
home / stock / mgnx / mgnx articles
SAN FRANCISCO, July 03, 2024 (GLOBE NEWSWIRE) -- Hagens Berman urges MacroGenics, Inc. (NASDAQ:MGNX) investors who suffered substantial losses t...
Shares of Science Applications International Corporation (NASDAQ:SAIC) declined 11% to $119.91 following first-quarter results. SAIC reported a 9% ...
NEW YORK, May 14, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigatin...
SAN FRANCISCO, May 10, 2024 (GLOBE NEWSWIRE) -- Hagens Berman urges MacroGenics, Inc. (NASDAQ:MGNX) investors who suffered substantial losses to...
MacroGenics Inc (NASDAQ:MGNX) released interim data from the TAMARACK Phase 2 study of vobramitamab duocarmazine (vobra duo). TAMARA...
U.S. stocks traded mixed toward the end of trading, with the Dow Jones gaining around 100 points on Friday. The Dow traded up 0.24% to 39,482.36 wh...
Shares of Diodes Incorporated (NASDAQ:DIOD) fell sharply during Friday's session after the company reported worse-than-expected quarterly fina...
U.S. stocks traded mixed midway through trading, with the Nasdaq Composite falling around 0.2% points on Friday. The Dow traded up 0.12% to 39,516....
On Thursday, MacroGenics Inc (NASDAQ:MGNX) released interim data from the TAMARACK Phase 2 study of vobramitamab duocarmazine (vobra duo) that ...
News, Short Squeeze, Breakout and More Instantly...
SAN FRANCISCO, July 03, 2024 (GLOBE NEWSWIRE) -- Hagens Berman urges MacroGenics, Inc. (NASDAQ: MGNX) investors who suffered substantial losses to submit your losses now . Visit: www.hbsslaw.com/investor-fraud/mgnx Contact the Firm Now: MGNX@hbsslaw.com 844-916...
2024-05-23 20:30:04 ET BTIG analyst issues BUY recommendation for MGNX on May 23, 2024 06:39PM ET. The previous analyst recommendation was Buy. MGNX was trading at $4.63 at issue of the analyst recommendation. The overall analyst consensus : BUY. Current analyst reco...
2024-05-23 20:00:06 ET Kaveri Pohlman from BTIG issued a price target of $9.00 for MGNX on 2024-05-23 18:39:00. The adjusted price target was set to $9.00. At the time of the announcement, MGNX was trading at $4.63. The overall price target consensus is at $15.00 with hi...